During 2014-2018 the Brazilian, Chinese and Indian markets grew by 11.4%, 7.3% and 11.2% respectively, compared to an average growth of 5.0% in the top 5 EU markets and 7.8% in the US.7European Federation of Pharmaceutical Industries and Associations. (2019).